The spinal cord injury therapeutics sector is expanding rapidly, fueled by rising trauma cases and advancements in regenerative medicine. Emerging therapies like stem cell treatments and neuroprotection drugs are transforming care paradigms. Major players including Lineage Cell Therapeutics, ReNetX Bio, and NervGen Pharma are driving innovation through clinical-stage programs targeting neural repair and functional recovery.

View Complete Market Report:
https://www.delveinsight.com/i....nfographics/spinal-c